Intratumoral administration was required for simultaneous tumor and LN labeling, as peritumorally delivered αCD45-IL-15 efficiently labeled the TDLNs but failed to accumulate in the tumor (Extended Data Fig. 5h). The gene discussed is IL15; the disease is neoplasm.